Cochrane Evidence Synthesis and Methods ►

Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol

To evaluate the effectiveness and safety of immune checkpoint inhibitors in people with stage I to III NSCLC who receive surgery or radiotherapy with curative intent.

This is a protocol.

Health topics:

Cancer > Lung > Non-small cell

Lungs & airways > Lung cancer > Non-small cell

Published:

25 June 2019

Authors:

Zhu Z, Zhang K, Cai N, Charbek E, Miller AC, Zhu S, Suo C, Chen X, Song H

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Zhu Z, Zhang K, Cai N, Charbek E, Miller AC, Zhu S, Suo C, Chen X, Song H. Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol. Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD013364. DOI: 10.1002/14651858.CD013364